Zynex, Inc. (ZYXI)

US — Healthcare Sector
Peers: HSIC  OMI  ABC  CAH  PDCO  MCK  EDAP 

Automate Your Wheel Strategy on ZYXI

With Tiblio's Option Bot, you can configure your own wheel strategy including ZYXI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ZYXI
  • Rev/Share 5.455
  • Book/Share 0.6573
  • PB 3.2556
  • Debt/Equity 3.5159
  • CurrentRatio 3.4574
  • ROIC -0.0592

 

  • MktCap 64711246.0
  • FreeCF/Share -0.014
  • PFCF -146.075
  • PE -9.1247
  • Debt/Assets 0.6906
  • DivYield 0
  • ROE -0.237

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 2
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade ZYXI Ladenburg Thalmann Buy Neutral -- -- March 12, 2025
Downgrade ZYXI RBC Capital Mkts Outperform Sector Perform $11 $5.5 March 12, 2025

News

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zynex, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZYXI
ZYXI
Published: March 25, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , March 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zynex, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZYXI
ZYXI STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zynex, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ZYXI
Published: March 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zynex securities between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period").

Read More
image for news ZYXI STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zynex, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Levi & Korsinsky Reminds Zynex, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 19, 2025 - ZYXI
ZYXI
Published: March 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-form?prid=138439&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds Zynex, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 19, 2025 - ZYXI
ZYNEX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Zynex, Inc. and Encourages Investors to Contact the Firm
ZYXI
Published: March 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ:ZYXI) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Zynex securities between March 13, 2023 and March 11, 2025, both dates inclusive (the “Class Period”). Investors have until May 19, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read More
image for news ZYNEX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Zynex, Inc. and Encourages Investors to Contact the Firm
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 19, 2025 in Zynex, Inc. Lawsuit - ZYXI
ZYXI
Published: March 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-form?prid=138329&wire=1 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 19, 2025 in Zynex, Inc. Lawsuit - ZYXI
Law Offices of Frank R. Cruz Encourages Zynex, Inc. (ZYXI) Investors To Inquire About Securities Fraud Class Action
ZYXI
Published: March 24, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Zynex, Inc. (ZYXI) Investors To Inquire About Securities Fraud Class Action.

Read More
image for news Law Offices of Frank R. Cruz Encourages Zynex, Inc. (ZYXI) Investors To Inquire About Securities Fraud Class Action
ZYXI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zynex, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ZYXI
Published: March 24, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zynex securities between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period").

Read More
image for news ZYXI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zynex, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Xynex, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZYXI
ZYXI
Published: March 23, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Zynex, Inc. ("Zynex" or the "Company") (NASDAQ:ZYXI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Xynex, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZYXI
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zynex, Inc. (ZYXI) And Encourages Stockholders to Connect
ZYXI
Published: March 21, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI). Investors who purchased Zynex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ZYXI.

Read More
image for news Bronstein, Gewirtz & Grossman, LLC Is Investigating Zynex, Inc. (ZYXI) And Encourages Stockholders to Connect
Law Offices of Howard G. Smith Encourages Zynex, Inc. (ZYXI) Investors To Inquire About Securities Fraud Class Action
ZYXI
Published: March 21, 2025 by: Business Wire
Sentiment: Neutral

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) securities between March 13, 2023 and March 11, 2025, inclusive (the “Class Period”). Zynex investors have until May 19, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZYNEX, INC. (ZYXI) CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONG.

Read More
image for news Law Offices of Howard G. Smith Encourages Zynex, Inc. (ZYXI) Investors To Inquire About Securities Fraud Class Action
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
ZYXI
Published: March 20, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI). Investors who purchased Zynex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ZYXI.

Read More
image for news Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Securities Fraud Investigation Into Zynex, Inc. (ZYXI) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
ZYXI
Published: March 19, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZYNEX, INC. (ZYXI), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 11, 2025, after market hours, Zynex released its fourth quarter and full.

Read More
image for news Securities Fraud Investigation Into Zynex, Inc. (ZYXI) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Shareholder Rights Advocates at Levi & Korsinsky Investigate Zynex, Inc. (ZYXI) Regarding Possible Securities Fraud Violations
ZYXI
Published: March 19, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zynex, Inc. ("Zynex, Inc.") (NASDAQ:ZYXI) concerning possible violations of federal securities laws. Zynex reported its financial and operation results for the fourth quarter and full year ended December 31, 2024, announcing that "fourth quarter revenue was less than expected.

Read More
image for news Shareholder Rights Advocates at Levi & Korsinsky Investigate Zynex, Inc. (ZYXI) Regarding Possible Securities Fraud Violations
Bronstein, Gewirtz & Grossman, LLC Encourages Zynex, Inc. (ZYXI) Investors to Inquire about Securities Investigation
ZYXI
Published: March 18, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / March 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI). Investors who purchased Zynex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ZYXI.

Read More
image for news Bronstein, Gewirtz & Grossman, LLC Encourages Zynex, Inc. (ZYXI) Investors to Inquire about Securities Investigation
Zynex, Inc. (ZYXI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
ZYXI
Published: March 13, 2025 by: Business Wire
Sentiment: Neutral

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZYNEX, INC. (ZYXI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmit.

Read More
image for news Zynex, Inc. (ZYXI) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
INVESTOR ALERT: Investigation of Zynex, Inc. (ZYXI) Announced by Holzer & Holzer, LLC
ZYXI
Published: March 12, 2025 by: GlobeNewsWire
Sentiment: Neutral

ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) complied with federal securities laws. On March 11, 2025, Zynex reported its financial and operation results for the fourth quarter and full year ended December 31, 2024, announcing that “fourth quarter revenue was less than expected. The shortfall was due to slower than normal payments from certain payers and we were recently notified that Tricare has temporarily suspended payments as they review prior claims.” Following this announcement, the price of the Company's stock dropped.

Read More
image for news INVESTOR ALERT: Investigation of Zynex, Inc. (ZYXI) Announced by Holzer & Holzer, LLC
Zynex's Sell-Off Creates A Speculative Buying Opportunity
ZYXI
Published: March 12, 2025 by: Seeking Alpha
Sentiment: Positive

Zynex, Inc. specializes in non-invasive pain management and patient monitoring, with promising advancements like the NiCO pulse oximeter targeting accurate readings for diverse skin tones. Despite disappointing Q4 2024 results and reimbursement challenges, Zynex aims for long-term growth with cost-cutting measures and a strategic market entry plan for NiCO. Valuation concerns arise from high current P/E ratios, but projected forward P/E compression suggests potential deep-value in the growing medical device market.

Read More
image for news Zynex's Sell-Off Creates A Speculative Buying Opportunity
Zynex Sets Fourth Quarter and Year End 2024 Earnings Call
ZYXI
Published: March 03, 2025 by: PRNewsWire
Sentiment: Neutral

ENGLEWOOD, Colo. , March 3, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, March 11, 2025 at 4:15 PM Eastern Time to discuss its financial results for the fourth quarter and year ended December 31, 2024.

Read More
image for news Zynex Sets Fourth Quarter and Year End 2024 Earnings Call
Zynex COO on pain management innovations and growth plans – ICYMI
ZYXI
Published: February 28, 2025 by: Proactive Investors
Sentiment: Positive

Zynex Inc (NASDAQ:ZYXI) COO Anna Lucsok shared insights earlier this week about the company's operational strategies and future growth plans in an interview with Proactive. Lucsok discussed the company's strong performance in sales and reimbursement, as well as its mission to provide non-opioid pain management solutions.

Read More
image for news Zynex COO on pain management innovations and growth plans – ICYMI

About Zynex, Inc. (ZYXI)

  • IPO Date 2004-02-25
  • Website https://www.zynex.com
  • Industry Medical - Distribution
  • CEO Mr. Thomas Sandgaard
  • Employees 1000

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.